IL10 and rheumatoid arthritis: CD56+ monocytes produce more tumor necrosis factor (TNF), interleukin 10 (IL-10) and IL-23 than CD56– monocytes, and anti-TNF therapy normalizes the frequency of CD56+ monocytes in RA patients.